These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15307886)

  • 41. [Rofecoxib and gynecomastia: the first case].
    Schmutz JL; Barbaud A; Trechot P
    Ann Dermatol Venereol; 2004; 131(8-9):856. PubMed ID: 15505566
    [No Abstract]   [Full Text] [Related]  

  • 42. Tolerability of rofecoxib versus naproxen.
    Jenkinson ML
    Ann Intern Med; 2004 Jun; 140(12):1059-60; author reply 1060. PubMed ID: 15197027
    [No Abstract]   [Full Text] [Related]  

  • 43. Tolerability of rofecoxib versus naproxen.
    Rusche JM
    Ann Intern Med; 2004 Jun; 140(12):1059; author reply 1060. PubMed ID: 15197028
    [No Abstract]   [Full Text] [Related]  

  • 44. Vioxx doctors wooed by Merck are now its foes.
    Tesoriero HW
    Wall St J (East Ed); 2006 Mar; ():B1, B3. PubMed ID: 16578911
    [No Abstract]   [Full Text] [Related]  

  • 45. [Severe acute cholestatic and cytolytic hepatitis induced by rofecoxib].
    Ouar S; Bellaïche G; Belloc J; Tordjman G; Ley G; Slama JL
    Gastroenterol Clin Biol; 2005 Apr; 29(4):471-2. PubMed ID: 15918218
    [No Abstract]   [Full Text] [Related]  

  • 46. The great rofecoxib feeding frenzy.
    Van Way CW
    JPEN J Parenter Enteral Nutr; 2005; 29(2):136-8. PubMed ID: 15772394
    [No Abstract]   [Full Text] [Related]  

  • 47. Tolerability of rofecoxib versus naproxen.
    Hanauer LB
    Ann Intern Med; 2004 Jun; 140(12):1059; author reply 1060. PubMed ID: 15197026
    [No Abstract]   [Full Text] [Related]  

  • 48. Delirium From the COX-2 inhibitor refecoxib.
    Muralee S; Bober D; Tampi R
    Psychosomatics; 2004; 45(4):361-3. PubMed ID: 15232052
    [No Abstract]   [Full Text] [Related]  

  • 49. A rare case of rofecoxib-induced cholestatic hepatitis.
    Harsch IA; Michaeli P; Hahn EG; Konturek PC; Klein R
    Dig Liver Dis; 2003 Dec; 35(12):911-2. PubMed ID: 14703890
    [No Abstract]   [Full Text] [Related]  

  • 50. Angioedema associated with aspirin and rofecoxib.
    Marshall LL
    Ann Pharmacother; 2005 May; 39(5):944-8. PubMed ID: 15811906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does the pro-hypertensive effect of cyclooxygenase-2 inhibitors account for the increased risk in cardiovascular disease?
    Messerli FH; Sichrovsky T
    Am J Cardiol; 2005 Sep; 96(6):872-3. PubMed ID: 16169380
    [No Abstract]   [Full Text] [Related]  

  • 52. Rofecoxib-induced cholestatic hepatitis: treatment with molecular adsorbent recycling system (MARS).
    Huster D; Schubert C; Berr F; Mössner J; Caca K
    J Hepatol; 2002 Sep; 37(3):413-4. PubMed ID: 12175641
    [No Abstract]   [Full Text] [Related]  

  • 53. [Overestimated].
    Höer A; Häussler B
    Med Klin (Munich); 2006 Aug; 101(8):676-7; author reply 678-9. PubMed ID: 17051671
    [No Abstract]   [Full Text] [Related]  

  • 54. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.
    Johnsen SP; Larsson H; Tarone RE; McLaughlin JK; Nørgård B; Friis S; Sørensen HT
    Arch Intern Med; 2005 May; 165(9):978-84. PubMed ID: 15883235
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Leukocytoclastic vasculitis related to rofecoxib.
    Palop-Larrea V; Melchor-Penella MA; Ortega-Monzó C; Martínez-Mir I
    Ann Pharmacother; 2003 Nov; 37(11):1731-2. PubMed ID: 14565803
    [No Abstract]   [Full Text] [Related]  

  • 56. [Is there a future for COX-2 inhibitors?].
    Yodfat Y
    Harefuah; 2004 Nov; 143(11):820-4, 837. PubMed ID: 15603272
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Intestinal side effects of COX-2 inhibitors].
    Calvo N; Iversen E; Munck LK
    Ugeskr Laeger; 2006 Mar; 168(13):1343-4. PubMed ID: 16579892
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fatal haemorrhagic pulmonary oedema and associated angioedema after the ingestion of rofecoxib.
    Kumar NP; Wild G; Ramasamy KA; Snape J
    Postgrad Med J; 2002 Jul; 78(921):439-40. PubMed ID: 12151676
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The pain game.
    Wadman M
    Nature; 2007 Jul; 448(7152):400-1. PubMed ID: 17653159
    [No Abstract]   [Full Text] [Related]  

  • 60. Psoriasis associated with rofecoxib.
    Clark DW; Coulter DM
    Arch Dermatol; 2003 Sep; 139(9):1223. PubMed ID: 12975177
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.